1-9 of 9
Philipp Gödel
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Targeting Lymphoma Associated Myeloid-Monocytic Cells through CSF1R Blockade Enhances CAR-T Cell Response in Aggressive B Cell Lymphoma

David Stahl, Philipp Gödel, Hyatt Balke-Want, Paul Segbers, Luis Tetenborg, Rahil Gholamipoorfard, Daniel Bachurski, France Rose, Zinaida Good, Adrian G. Simon, Marieke Nill, Ruth Flümann, Tobias Riet, Janina Dörr, Stuart J. Blakemore, Herrad Baurmann, Conrad-Amadeus Voltin, Nicole Potter, Lilli Schlözer, Svenja Wagener-Ryczek, Andra-Iza Iuga, Jan-Michel Heger, Hanna Ludwig, Julia K. Schleifenbaum, Paul J. Bröckelmann, Ron D. Jachimowicz, Gero Knittel, Sven Borchmann, Sabine Merkelbach-Bruse, Christian Pallasch, Martin Peifer, Mark Nitz, Johannes Brägelmann, Werner Müller, Thorsten Persigehl, Katarzyna Bozek, Reinhard Büttner, Michael J. Hallek, Sebastian Kobold, Markus Chmielewski, Hans Christian Reinhardt, Crystal L. Mackall, Nima Abedpour, Peter Borchmann, Roland T. Ullrich
Journal: Blood
Blood (2024) 144 (Supplement 1): 367.
https://doi.org/10.1182/blood-2024-203291
Published: 2024
Journal Articles

Entirely noninvasive outcome prediction in central nervous system lymphomas using circulating tumor DNA

Jan-Michel Heger, Julia Mattlener, Jessica Schneider, Philipp Gödel, Noëlle Sieg, Fabian Ullrich, Richard Lewis, Teodora Bucaciuc-Mracica, Roland F. Schwarz, Daniel Rueß, Maximilian I. Ruge, Manuel Montesinos-Rongen, Martina Deckert, Tobias Blau, Nadine Kutsch, Hyatt Balke-Want, Jonathan Weiss, Kerstin Becker, H. Christian Reinhardt, Michael Hallek, Peter Borchmann, Bastian von Tresckow, Sven Borchmann
Journal: Blood
Blood (2024) 143 (6): 522–534.
https://doi.org/10.1182/blood.2023022020
Published: 2024
Includes: Supplemental data
Journal Articles

Noninvasive, Dynamic Risk Profiling of Primary Central Nervous System Lymphoma By Peripheral Blood Ctdna-Sequencing

Jan-Michel Heger, Julia Mattlener, Philipp Gödel, Hyatt Balke-Want, Noëlle Sieg, Nadine Kutsch, Kerstin Becker, Jonathan Weiss, H. Christian Reinhardt, Michael Hallek, Peter Borchmann, Bastian von Tresckow, Sven Borchmann
Journal: Blood
Blood (2022) 140 (Supplement 1): 3537–3538.
https://doi.org/10.1182/blood-2022-162420
Published: 2022
Journal Articles

Characterization and T-Cell Repertoire of MB-CART2019.1 (Zamtocabtagene autoleucel) - Data from the Phase I Trial in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

Tatjana Holzer, Stefanie Biedermann, Inga Herfort, Birte Friedrichs, Silke Holtkamp, Linda Hanssens, Mario Assenmacher, Ulf Bethke, Dina Schneider, Stefan Miltenyi, Toon Overstijns, Christoph Schmid, Francis A. Ayuk, Christoph Scheid, Anja Jühling, Udo Holtick, Philipp Gödel, Peter Borchmann, Iris Bürger
Journal: Blood
Blood (2022) 140 (Supplement 1): 4581–4583.
https://doi.org/10.1182/blood-2022-164597
Published: 2022
Journal Articles

A Phase I Dose Finding Trial of MB-CART20.1 in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

Nadine Kutsch, Philipp Gödel, Udo Holtick, Anja Lohneis, Vladan Vucinic, Florentine Pia Altefrohne, Christin Schubert, Sandra Karitzky, Linda Hanssens, Mario Assenmacher, Iris Bürger, Murat Aktas, Peter Borchmann
Journal: Blood
Blood (2022) 140 (Supplement 1): 12980–12981.
https://doi.org/10.1182/blood-2022-168730
Published: 2022
Journal Articles

Inferior Outcomes of EU Vs. US Patients with Relapsed/Refractory Large B-Cell Lymphoma after CD19 CAR T-Cell Therapy Are Associated with Differences in Tumor Burden, Systemic Inflammation, Bridging Therapy Utilization and CAR-T Product Selection

Veit L Buecklein, Ariel Perez-Perez, Kai Rejeski, Gloria Iacoboni, Vindi Jurinovic, Udo Holtick, Olaf Penack, Soraya Kharboutli, Viktoria Blumenberg, Josephine Ackermann, Lisa Frölich, Grace Johnson, Kedar Patel, Brian Arciola, Christian Schmidt, Omar Albanyan, Philipp Gödel, Eva Hoster, Lars Bullinger, Andreas Mackensen, Frederick L. Locke, Michael von Bergwelt, Pere Barba, Michael D. Jain, Marion Subklewe
Journal: Blood
Blood (2022) 140 (Supplement 1): 2411–2413.
https://doi.org/10.1182/blood-2022-165452
Published: 2022
Journal Articles

Impact of Timing and Precision of Histopathological Diagnosis on Outcomes of Patients with Burkitt and High-Grade B-Cell Lymphoma

Jan-Michel Heger, Claus Moritz Graef, Philipp Falderbaum, Philipp Gödel, Hyatt Balke-Want, Florian Simon, Noëlle Sieg, Jan-Hendrik Naendrup, Marie Anne-Catherine Neumann, Sarah Gillessen, Paul J Bröckelmann, Dennis A. Eichenauer, Peter Borchmann, Bastian Von Tresckow
Journal: Blood
Blood (2021) 138 (Supplement 1): 2531.
https://doi.org/10.1182/blood-2021-145283
Published: 2021
Journal Articles

Phase I Trial of MB-CART2019.1, a Novel CD20 and CD19 Targeting Tandem Chimeric Antigen Receptor, in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

Peter Borchmann, Anja Jühling, Philipp Gödel, Hyatt Balke-Want, Christoph Schmid, Francis A. Ayuk, Silke Holtkamp, Liane Preussner, Gregor Zadoyan, Linda Hanssens, Andrew Kaiser, Marion Jurk, Iris Bürger, Dina Schneider, Boro Dropulic, Toon Overstijns, Christof Scheid, MD, Udo Holtick, Stefan Miltenyi, Michael Hallek
Journal: Blood
Blood (2020) 136 (Supplement 1): 48.
https://doi.org/10.1182/blood-2020-136067
Published: 2020
Journal Articles

Clonal Evolution of a Mutation in PTPRA As a Potential Cause for Resistance Against Anti-CD19 Directed Chimeric Antigen Receptor T-Cell (CAR-T) Therapy with CTL019 in DLBCL Patients

Hyatt Balke-Want, MD, Philipp Gödel, MD, Nima Abedpour, PhD, Martin Peifer, PhD, Peter Borchmann, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4119.
https://doi.org/10.1182/blood-2018-99-110600
Published: 2018